Fangfang Han
Cancer Research · 2023
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 47 citations into it
- Genetics — 8 citations into it
Whom Fangfang Han trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Fangfang Han's perspective
Ordered by how strongly the researchers Fangfang Han trusts endorse each paper. Same corpus, a different order for every researcher.
- Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* (Journal of Biological Chemistry)
- Oxygen sensing by HIF hydroxylases (Nature reviews. Molecular cell biology)
- Oxygen sensing, homeostasis, and disease. (New England Journal of Medicine)
- Hypoxia-Inducible Factors in Physiology and Medicine (Cell)
- HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. (Cancer Cell)
- HIF-1 as a target for drug development (Nature reviews. Drug discovery)
- Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. (Cancer Cell)
- Immune regulatory function of B cells. (Annual Review of Immunology)
- Inhibitory effect of tumor cell-derived lactic acid on human T cells. (Blood)
- Hypoxia enhances the generation of induced pluripotent stem cells.
Their papers
- Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions (2023) — 1,300 citations